Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Annal Meleth (NPI 1962668046)

Field	Value
Entity Type	Individual
Organization	Annal Meleth
Address	895 Canton Rd Ne
City	Marietta
State	GA
ZIP	30060
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 29, 2008

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

Practice is centered on office‑administered intravitreal biologic therapy and retina diagnostics: the single largest revenue source is J2777 (faricimab) with 31.6K claims and $915.2K revenue (41.0% of Medicare revenue), followed by J0178 (aflibercept) with 1.1K claims and $740.6K revenue (33.2%). These drug codes dominate the clinical mix and are complemented by diagnostic and office E/M codes like 92014 and 92134, indicating a retina-focused ophthalmology practice that delivers injections and associated imaging in the office setting.

Medicare revenue is highly concentrated: the top 3 Medicare codes (J2777, J0178, J3590) account for 79.1% of this provider's total Medicare revenue, underscoring dependence on a small set of high‑value biologic drug codes for the bulk of billing. That concentration means changes in utilization patterns, drug prices, or reimbursement for these codes would disproportionately affect this provider's Medicare revenue.

This provider is effectively single‑payer at the dataset level: lifetime Medicare revenue is reported as $2.2M while Medicaid billing is listed as none, so the practice has no Medicaid footprint on file and relies on Medicare as its primary public payer. The absence of Medicaid claims limits visibility into lower‑reimbursing payer segments and indicates a narrow public‑payer exposure.

Competitive standing on the main drug codes is mixed: J2777 ranks #271 of 2039 nationally (87th percentile; typical, unremarkable volume for this code), showing an above‑median national position on faricimab claims while still being characterized as typical volume. J0178 ranks #1198 of 3204 (63th percentile; typical, unremarkable volume for this code), indicating a more modest national presence for aflibercept relative to peers.

Diagnostic and established‑patient visit volumes are relatively high versus national peers: 92014 has 1.2K claims and $108K revenue (4.8%) and ranks #1063 of 35415 (97th percentile; notably above typical national volume for this code), and 92134 has 1.8K claims and $54.8K revenue (2.5%) and ranks #1194 of 26868 (96th percentile; notably above typical national volume for this code). These ranks suggest the provider maintains larger-than‑typical volumes of established patient exams and OCT imaging compared with most ophthalmologists nationally.

Procedural surgical volume appears limited relative to peers: 67036 (vitrectomy) shows only 13 claims and $8.2K revenue (0.4%) and ranks #649 of 832 providers (15th percentile; typical, unremarkable volume for this code), implying the practice performs few posterior‑segment surgeries and is more office‑based and injection‑focused. This pattern aligns with the dominance of intravitreal drug administration in the revenue mix.

Tenure and stability: the provider's NPI was enumerated on 2008-07-29 (~18 years ago), indicating a long‑standing billing history in Medicare which supports the observed established patient and imaging volumes. Long tenure combined with the high share of established‑patient exams (92014) suggests a stable patient panel and sustained service lines over time.

Operational and financial sensitivity: because J2777 and J0178 together comprise a large share of Medicare revenue ($915.2K and $740.6K respectively) and the top three codes make up 79.1% of Medicare income, the practice is materially exposed to shifts in biologic utilization, reimbursement policies, or drug pricing. The lack of Medicaid billing on file further narrows payer diversification, concentrating revenue risk on Medicare developments.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	31,560	$30	$915.2K
J0178	Injection, aflibercept, 1 mg	1,090	$680	$740.6K
J3590	Unclassified biologics	50	$2,120	$108.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,210	$90	$108K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,110	$90	$101.7K
J3490	Unclassified drugs	60	$1,730	$100.2K
J2778	Injection, ranibizumab, 0.1 mg	360	$180	$65.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,830	$30	$54.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	120	$90	$10.9K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	10	$630	$8.2K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Annal Meleth — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	31	70	970	$680	$700.6K
J2777	8	40	14,100	$30	$524.3K
J2778	23	30	1,170	$180	$286.2K
J3590	1	10	40	$2,120	$78.4K
67028	29	80	720	$90	$71.9K
67036	9	10	20	$1,120	$23.6K
J3490	23	50	50	$320	$19.8K
92014	14	850	130	$80	$19.7K
99214	6,667	13,640	120	$80	$17.8K
J9035	59	70	120	$50	$10.3K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Annal Meleth, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
Charles Wykoff	TX	Ophthalmology Physician	$6.2M	$0
Matthew Benz	TX	Ophthalmology Physician	$5.7M	$0
David Brown	TX	Ophthalmology Physician	$5.7M	$0
Tien Wong	TX	Ophthalmology Physician	$4.5M	$0
Jay Wang	FL	Medical Oncology Physician	$4.5M	$0
Joseph Sedrak	TX	MOHS-Micrographic Surgery Physician	$4.4M	$0
Ankoor Shah	TX	Ophthalmology Physician	$3.7M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
James Major	TX	Ophthalmology Physician	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Annal Meleth, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Quantum Radiology, PC	GA	Diagnostic Radiology Physician	$0	$4.3M
Robert Stoltz	GA	Specialist	$2.6M	$0
Weijian Zhu	GA	Anatomic Pathology & Clinical Pathology Physician	$2.6M	$4.7K
Marietta Eye Clinic, PA	GA	Ophthalmologic Surgery Clinic/Center	$2.5M	$0
Jeffrey Winter	GA	Vascular Surgery Physician	$2.4M	$0
Kennestone Hospital, Inc.	GA	General Acute Care Hospital	$0	$1.9M
Lakshmana Kooragayala	GA	Ophthalmology Physician	$1.8M	$0
Kevin Thomas	GA	Dermatopathology (Pathology) Physician	$1.6M	$0
Mark Chastain	GA	Dermatology Physician	$1.6M	$0
Marietta Advanced Surgery Center	GA	Ambulatory Surgical Clinic/Center	$1.3M	$0

Annal Meleth — Billing Profile & Reimbursement Data

Sign up for Annal Meleth — Billing Profile & Reimbursement Data policy alerts

Annal Meleth — Billing Profile & Reimbursement Data

Sign up for Annal Meleth — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References